David Aronoff
-
March 18, 2020
Ibuprofen and COVID-19: a doctor’s guidance
Last week, France’s health ministry urged people who have been infected by the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) to avoid taking over-the- counter nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen and aspirin because they might increase the severity of the infection. -
September 24, 2019
Treating C. diff: new purpose for an old drug?
An inexpensive generic drug once used to prevent gastrointestinal ulcers in people taking daily NSAIDs protects against C. diff infection in mice. -
July 24, 2019
Major grant renews AIDS education, training initiative
VUMC has been awarded a five-year, nearly $23 million federal grant to continue coordinating AIDS education and training efforts in Tennessee and seven other southeastern states. -
July 11, 2019
Vanderbilt team shows how stomach bug can trigger cancer
Researchers at Vanderbilt University and the University of Michigan in Ann Arbor have obtained the first high-resolution image of a molecular “machine” used by the insidious stomach bug Helicobacter pylori (H. pylori) to inject a cancer-causing protein into the stomach lining. -
January 17, 2019
Pain relievers a risk for C. diff?
A link between anti-inflammatory drugs such as ibuprofen and C. diff infection suggests caution against overusing such drugs in patients at high risk for infection. -
October 26, 2018
Fetal membranes and microbial threats
Understanding how cells communicate in the membranes surrounding the developing fetus could suggest new strategies for preventing infections, premature birth and adverse pregnancy outcomes. -
April 19, 2018
VUMC drug repurposing initiative gaining momentum
Drug repurposing involves establishing an additional approved indication for a drug already at market.